Sugi Predict

Sugi Predict / Targets / MAP7D3

MAP7D3

MAP7 domain-containing protein 3 · Q8IWC1 · MAP7D3 on Sugi Atlas →

0 patent compounds predicted against MAP7D3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MAP7D3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) PHASE2/PHASE3ACTIVE_NOT_RECRUITING
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome PHASE3COMPLETED
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
Family Blood Pressure Program - GenNet Network nanCOMPLETED
Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease nanRECRUITING
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD) nanCOMPLETED
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED
Family Blood Pressure Program - GENOA nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Enhanced Linkage Maps From Family-Based Genetics Studies nanCOMPLETED
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
Muscle Wasting in Cancer (MWIC) nanCOMPLETED
Neurofilament Surveillance Project (NSP) nanACTIVE_NOT_RECRUITING
Immune Cell Response to Stimuli nanRECRUITING
Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm nanCOMPLETED
Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH) nanRECRUITING
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature. nanUNKNOWN
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes nanCOMPLETED
Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS) nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a MAP7D3 binder may also engage these)

ProteinNameSimilarity
A2AEY4 — 1.000 A2AEY4 →
A2ARZ3 — 0.993 A2ARZ3 →
Q811D2 — 0.992 Q811D2 →
Q95J40 — 0.991 Q95J40 →
Q8BQ48 — 0.991 Q8BQ48 →
F1QIC4 — 0.990 F1QIC4 →
D4A4L4 — 0.990 D4A4L4 →
A6QP06 — 0.990 A6QP06 →
Q5VT06 — 0.990 Q5VT06 →
O54963 — 0.990 O54963 →
PEAK1 Inactive tyrosine-protein kinase PEAK1 0.990 landscape →
P10244 — 0.989 P10244 →
A7E3D8 — 0.989 A7E3D8 →
Q86V48 — 0.989 Q86V48 →
Q28DE6 — 0.989 Q28DE6 →
A6H5Y1 — 0.989 A6H5Y1 →
O60284 — 0.989 O60284 →
Q3T0A6 — 0.989 Q3T0A6 →
Q8BZ32 — 0.989 Q8BZ32 →
Q498L0 — 0.989 Q498L0 →
Q96JQ2 — 0.989 Q96JQ2 →
Q8IZ21 — 0.989 Q8IZ21 →
A0A2K1J5A5 — 0.989 A0A2K1J5A5 →
Q6NWJ0 — 0.989 Q6NWJ0 →
Q90ZS6 — 0.989 Q90ZS6 →
A0A1L8HFX9 — 0.989 A0A1L8HFX9 →
Q949U2 — 0.989 Q949U2 →
Q6A065 — 0.989 Q6A065 →
E9Q309 — 0.989 E9Q309 →
Q5CZC0 — 0.989 Q5CZC0 →